Eli Lilly reaches new heights with skyrocketing sales of Mounjaro, a diabetes drug popular for weight loss
INDIANAPOLIS — Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall …